Large-scale epidemiological studies have confirmed that metformin users have a significantly lower risk of developing various malignancies, including bladder, lung, prostate, pancreatic, head and neck, esophageal, liver, and colorectal cancers, compared to non-users [10]
If you are still early in the process, you can take the free assessment quiz to see whether a personalized GLP-1 program is a fit for you
Pharma marketers should intensify messaging around their weight loss drugs being cost-effective over the long haul by preventing more serious chronic diseases
They have been successfully employed in human papillomavirus vaccines and evaluated in candidates for COVID-19 immunization
In internal brand testing, 99.9% of the bacterial strain survived gut-like acidic conditions, and 98.2% of the bacteria remained alive through the point of consumption
PMID: 27186356 Dungan K, DeSantis A